Can medicines development improve outcomes in asthma and chronic obstructive pulmonary disease management by driving effectiveness?
Abstract Despite the availability of treatment guidelines and inhaled medications for asthma and chronic obstructive pulmonary disease (COPD), much remains to be done to lessen the burden of these respiratory diseases for patients. The challenge of selecting effective and efficacious drugs for patie...
Main Authors: | David A. Leather, Louisa Yates, Henrik Svedsater, Loretta Jacques, Susan Collier, Danielle Powell, Rupert Jones |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-08-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12931-019-1127-6 |
Similar Items
-
Airflow obstruction: is it asthma or is it COPD?
by: Rogliani P, et al.
Published: (2016-11-01) -
Assessment of the role of fractional exhaled nitric oxide in the diagnosis of asthma–chronic obstructive pulmonary disease overlap
by: Eman Shebl, et al.
Published: (2020-01-01) -
Overlap Syndrome in Respiratory Medicine: Asthma and Chronic Obstructive Pulmonary Disease
by: Alexandru Corlateanu, et al.
Published: (2014-02-01) -
Overlap Syndrome in Respiratory Medicine: Asthma and Chronic Obstructive Pulmonary Disease
by: Alexandru Corlateanu, et al.
Published: (2014-02-01) -
T-regulatory cells subpopulation in bronchial asthma and heterogeneous phenotypes of chronic obstructive pulmonary disease
by: N. A. Kirillova, et al.
Published: (2011-02-01)